Medical Decision Support Systems for Sepsis Market Report Size, Industry Growth and Expansion, Business Strategy, Forecast to 2022

This report aims to provide detailed insights into the global Medical Decision Support Systems for Sepsis Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Expected Revenue Growth: The global medical decision support systems for sepsis market is projected to reach USD 35.6 Million by 2022 from USD 12.0 Million in 2017, at a CAGR of 24.3%. Increasing funding and research grants, growing pressure to curb healthcare spending, and improving patient outcomes are driving the growth of this market.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227232851

Objectives of the Study:

  • To define, describe, and forecast the global medical decision support systems for sepsis market on the basis of region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
  • To strategically analyze the market structure and profile the key players of global clinical decision support systems and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as agreements, collaborations, and partnerships; product launches, enhancements, & integrations; and acquisitions in the CDSS market

Research Methodology:

Top-down and bottom-up approaches were used to estimate and validate the size of the global medical decision support systems for sepsis industry in the overall market.

Various secondary sources such as associations like Healthcare Information and Management Systems Society (HIMSS), American Medical Informatics Association (AMIA), Global Sepsis Alliance, Surviving Sepsis Campaign (SSC), Agency for Healthcare Research and Quality (AHRQ), American Association of Healthcare Administrative Management (AAHAM), American Journal of Medicine, Journal of the American Medical Association (JAMA), Organisation for Economic Co-operation and Development (OECD), World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Institute for Health Technology Transformation (iHT2), American Medical Group Association (AMGA), The LANCET Infectious Diseases, International Association of Health Policy (IAHP), UK Sepsis Trust, National Health Services (NHS), Institute of Population and Public Health (IPPH), European Federation for Medical Informatics (EFMI), Australian Sepsis Network, Expert Interviews, Investor Presentations, SEC Filings, Company Annual Reports, and MarketsandMarkets Analysis have been used to identify and collect information useful for the study of this market.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=227232851

Key Market Player

The prominent market players offering medical decision support systems for sepsis include Wolters Kluwer Health (US), Cerner Corporation (US), Philips Healthcare (Netherlands), Amara Health Analytics (US), McKesson Corporation (US), Ambient Clinical Analytics (US), Iatric Systems Inc. (US), PeraHealth Inc. (US), Health Catalyst Inc. (US), and Allscripts Healthcare Solutions, Inc. (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Comments are closed